This article was originally published in The Rose Sheet
Executive SummaryFine fragrance sales rose 9% for the second quarter, contributing to a net sales increase of 2.9% to $530.5 mil., International Flavors & Fragrances announces July 26. The performance of fine fragrances was attributed to new product introductions and strong sales of the North American and Latin American divisions, which grew 18% and 17%, respectively. "The fine fragrance team is executing its strategy of building customer brands around the world very well," IFF says. Net fragrance sales advanced 3% with a 1% increase in functional fragrance and a 3% decrease in fragrance ingredient sales, company notes. Net income rose 7.8% to $61.2 mil...
You may also be interested in...
Oncologic Drugs Advisory Committee will consider whether a statistically significant benefit on progression-free survival, but no survival advantage, is enough to secure a first-line lung cancer indication for ramucirumab.
Whoever takes over as chair of the Medicines and Healthcare products Regulatory Agency will play a key role in its plans to deliver a program of “ambitious business change.”
Perrigo has received US FDA approval for a generic version of Teva’s ProAir albuterol inhaler. The firm is immediately launching a “limited quantity” but is also ramping up production with partner Catalent to meet future demand.